|6 Months Ended
Jun. 30, 2022
|Share-Based Payment Arrangement [Abstract]
At June 30, 2022, the intrinsic value of the outstanding options was $.
During the six months ended June 30, 2022, the Company granted stock options to certain employees and consultants to purchase a total of 374 and $905, respectively. As of June 30, 2022, the remaining share-based compensation expense associated with previously issued stock options was $ , which will be recognized in future periods as the options vest. shares of common stock for services rendered or to be rendered. The options have an average exercise price of $ per share, terms between one and five years, and vest between zero and four years from the respective grant dates. The total grant date fair value of these options was approximately $ using the Black-Scholes option pricing model. The total share-based compensation expense recognized relating to the vesting of stock options for the three and six months ended June 30, 2022, was $
During the six months ended June 30, 2022, a total of 377. stock options were exercised. As a result of the exercise of the option, the Company issued shares of common stock and received cash of $
The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award; the expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; and the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future.